viasil comprimate filmate 50 mg
lekpharm srl - sildenafilum - comprimate filmate - 50 mg
zoely 2,5 mg + 1,5 mg comprimate filmate
schering-plough central east ag - nomegestrolum + estradiolum - comprimate filmate - 2,5 mg + 1,5 mg
atropin sulfat solutie injectabila 1 mg/ml
gntls srl, uzina experimentala - atropini sulfas - solutie injectabila - 1 mg/ml
azicin- comprimate filmate 250 mg
gracure pharmaceuticals ltd. - azithromycinum - comprimate filmate - 250 mg
azicin- comprimate filmate 500 mg
gracure pharmaceuticals ltd. - azithromycinum - comprimate filmate - 500 mg
caditor comprimate filmate 80 mg
cadila pharmaceuticals ltd - atorvastatinum - comprimate filmate - 80 mg
improvac
zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - imunologii pentru suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. un alt factor care contribuie la mâncarea de mistreți, skatole, poate fi de asemenea redus ca efect indirect. comportamentele agresive și sexuale (de montare) sunt de asemenea reduse. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - porci - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
lemtrada 10 mg/ml concentrat pentru soluţie perfuzabilă
sanofi belgium - alemtuzumabum - concentrat pentru soluţie perfuzabilă - 10 mg/ml
rabeloc comprimate filmate gastrorezistente 10 mg
cadila pharmaceuticals ltd - rabeprazolum - comprimate filmate gastrorezistente - 10 mg